RT Journal Article
SR Electronic
T1 The Association of NICU Strain with Neonatal Mortality and Morbidity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.07.24310050
DO 10.1101/2024.07.07.24310050
A1 Salazar, Elizabeth G.
A1 Passarella, Molly
A1 Formanowski, Brielle
A1 Rogowski, Jeannette
A1 Edwards, Erika
A1 Phibbs, Ciaran
A1 Lorch, Scott A.
YR 2024
UL http://medrxiv.org/content/early/2024/07/08/2024.07.07.24310050.abstract
AB Objective To examine the association of admission NICU strain with neonatal mortality and morbidity.Study Design 2008-2021 South Carolina cohort using linked vital statistics and discharge data of 22-44 weeks GA infants, born at hospitals with ≥ level 2 unit and ≥5 births of infants <34 weeks GA/year. The exposure was tertiles of admission NICU strain, defined as the sum of infants <44 weeks GA with a congenital anomaly plus all infants born <33 weeks GA at midnight on the day of birth. We used Poisson generalized linear mixed models to examine the association of exposure to strain with the primary outcome of a composite of mortality and term and preterm morbidities adjusting for patient and hospital characteristics.Results We studied 64,647 infants from 30 hospitals. High strain was associated with increased risk of mortality and morbidity adjusting for patient/hospital factors (aIRR 1.07, 95% CI 1.01 – 1.12).Conclusion NICU strain is associated with increased adverse outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementT32HL098054 (to EGS). R01HD084819 (to CSP, SAL).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Children's Hospital of Philadelphia institutional review board determined that the abstracted data did not meet the requirements of human subjects research. Data use was approved by the South Carolina Department of Health.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available should a data use agreement be reached with the source and a reasonable request made to the authors.CLDChronic Lung DiseaseGAGestational AgeIVHIntraventricular hemorrhageNECNecrotizing enterocolitisNICUNeonatal Intensive Care UnitPMAPost Menstrual AgeROPRetinopathy of prematuritysIVHSevere intraventricular hemorrhageVLBWVery low birth weight